secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0000950170-23-009177
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen board member Kristen Miranda resigns; Tom West appointed effective April 1, 2023
--------------------------------------------------------------------------------

- Kristen Miranda resigned as director effective March 31, 2023; not due to any disagreement with the company.
- Thomas A. West appointed to Board effective April 1, 2023; will serve as Class III director and on Nominating/Governance and Compliance Committees.
- West is President and CEO of Nalu Medical; previously CEO of Intersect ENT and held senior roles at Hologic and Johnson & Johnson.
- West receives annual cash fees of $45,000 for Board service and $5,000 per committee, plus initial RSU award of 1,712 shares vesting by June 8, 2023.
- Appointment expands board expertise in medtech and operational leadership as Inogen pursues growth transformation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023009177/0000950170-23-009177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023009177/ingn-20230319.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-009177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer